Background--Mechanistic studies suggest that aldosterone impairs glucose metabolism. We investigated the cross-sectional associations of aldosterone and plasma renin activity with fasting plasma glucose, insulin resistance (IR), b-cell function, and longitudinal association with incident diabetes mellitus among adults in MESA (the multiethnic study of atherosclerosis) prospective cohort study.
tion targets are of paramount importance, one potential target is the renin-angiotensin-aldosterone (RAAS). Aldosterone can impair insulin secretion and sensitivity, both of these actions are critical factors in the development of type 2 diabetes mellitus. [2] [3] [4] In a German case-control study, type 2 diabetes mellitus was more prevalent in subjects with primary aldosteronism (a state of high aldosterone, low angiotensin II and low plasma renin activity [PRA] , most commonly because of bilateral adrenal gland enlargement or adrenal adenomas) with hypertension than in hypertensive controls. 5 Among blacks in the Jackson Heart Study, 6 aldosterone was positively associated with insulin resistance, while higher levels of aldosterone across the spectrum were associated with a dose-dependent higher risk of the development of type 2 diabetes mellitus over 8 years. Recent observations demonstrate that aldosterone can be produced autonomously from aldosterone producing cell clusters within morphologically normal adrenal glands with a large spectrum and high prevalence of subclinical aldosteronism. [7] [8] [9] Thus, we examined the association of aldosterone and PRA with glucose metabolism and incident diabetes mellitus across the spectrum of aldosterone levels in a multiethnic cohort to determine if there are racial/ethnic differences.
Methods
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
MESA (the Multiethnic Study of Atherosclerosis) is a population-based sample of 6814 men and women from 4 racial/ ethnic groups: NHWs (38%), blacks (28%), Chinese Americans (12%), and Hispanic Americans (22%). Participants were aged 45 to 84 years at baseline without evidence of clinical cardiovascular disease. Details of sampling and recruitment are published. 10 The study was approved by the Institutional
Review Boards of the 6 participating institutions (Columbia University, New York; Johns Hopkins University, Baltimore; Northwestern University, Chicago; University of California, Los Angeles; University of Minnesota, Twin Cities; Wake Forest University, Winston Salem) and written informed consent was obtained from all participants. At exams 2 and 3 (%3 and 4.5 years after study baseline, respectively), a random subsample of 1959 MESA participants had PRA and aldosterone levels measured from stored blood as part of an ancillary study investigating calcified atherosclerosis of the renal arteries by computed tomography ( Figure S1 ). Of the participants with aldosterone and PRA measured, we excluded participants with: no or insufficient aldosterone sample (n=40); known diabetes mellitus or missing diabetes mellitus status at the exam of blood draw (n=334); missing data on follow-up (n=4); and missing data on important covariates (n=11). The final analytic sample included 1570 participants with aldosterone (602 and 968 participants from exams 2 and 3) and 1474 with PRA measurements (569 and 905 participants from exams 2 and 3), respectively. For continuous aldosterone analyses, 22 participants with aldosterone below the detectable range were excluded (n=1548). For this analysis, the baseline visit is the visit at which both aldosterone and PRA were measured.
Standardized questionnaires were used to obtain participant data including: demographics, level of education, alcohol consumption, medical conditions, and current prescription medication usage. Race/ethnicity was assessed by self-report and categorized as NHW, black, Hispanic American, or Chinese American. Education was carried forward from exam 1 and classified as bachelor's degree versus < bachelor's degree. Current alcohol use was assessed as a binary variable by asking participants if they "presently drink alcoholic beverages." Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) usage was collected at the exam of aldosterone and PRA measurement. The MESA Typical Week Physical Activity Survey, adapted from the Cross-Cultural Activity Participation Study, was used to assess physical activity. 11 We used the intentional exercise variable (sum of walking for exercise, sports/dancing, and conditioning in Metabolic Equivalent of Task-minutes/ week).
11
Calibrated devices were used to measure participants' weight, and height with body mass index calculated as weight (kilograms)/height 2 (meters). Waist circumference was measured at the level of the umbilicus. Resting seated blood pressure was measured 3 times using a Dinamap automated
Clinical Perspective
What Is New?
• In this contemporary, prospective study of multiethnic adults without type 2 diabetes mellitus, aldosterone was positively associated with fasting plasma glucose, insulin resistance, and risk of incident type 2 diabetes mellitus over 10.5 years.
• Type 2 diabetes mellitus risk per log-aldosterone standard deviation was higher among participants with both unsuppressed renin phenotype and suppressed renin phenotype suggesting physiologically, and autonomously higher aldosterone may increase risk of type 2 diabetes mellitus.
• Dose-dependent associations of aldosterone with incident type 2 diabetes mellitus existed in Chinese Americans and blacks but not in Hispanic Americans or non-Hispanic whites with the greatest magnitude of association among Chinese Americans.
What Are the Clinical Implications?
• Further clarification on the role of aldosterone in the development of diabetes mellitus and potential racial/ethnic differences is necessary to optimize risk stratification.
• Elucidation of mechanisms for the racial/ethnic differences in the association of aldosterone with incident type 2 diabetes mellitus is of preeminent importance given the potential to lower risk of type 2 diabetes mellitus through targeted modulation of the renin-angiotensin-aldosterone system. oscillometric sphygmomanometer (model Pro 100, Critikon, Tampa, FL); the last 2 measurements were averaged for analysis.
Laboratory Assessment
Covariates At visits, fasting (12-hours) blood samples were drawn in the morning after resting in the sitting position for 1 hour. Participants were instructed to take their usual medications before the clinic visit. Samples were processed using a standardized protocol and sent to the MESA central laboratory at the University of Vermont for further processing and storage. Participant samples were aliquoted into %65 aliquots per participant, immediately placed on ice, flash frozen, and stored at À80°C after processing. Serum glucose was measured by rate reflectance spectrophotometry using thin film adaptation of the glucose oxidase method on the Vitros analyzer (Johnson & Johnson Clinical Diagnostics, Rochester, NY). Insulin was determined using a radioimmunoassay Linco Human Insulin Specific RIA Kit (Linco Research). The homeostasis model assessment (HOMA)-2 of insulin resistance (HOMA2-IR) and b-cell function (HOMA2-b) were calculated using the updated computer-based HOMA index of insulin resistance (HOMA2-IR) and computer-based HOMA2-b% (https://www.dtu.ox.ac. uk/homacalculator/). 12 Serum creatinine was measured by rate reflectance spectrophotometry using thin-film adaptation of the creatinine amidinohydrolase method on the VITROS analyzer (Johnson & Johnson Clinical Diagnostics) and calibrated to Cleveland Clinic. Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. 13 Adiponectin, leptin, and tumor necrosis factor-a were measured by Human Serum Adipokine Panel A and B LINCOplex Kit (Linco Research, Inc., St. Charles, MO). All assays were performed at the Laboratory for Clinical Biochemistry Research (University of Vermont, Burlington, VT).
Exposures-PRA and aldosterone
Aldosterone and PRA were measured after 2 and 3 freezethaw cycles, respectively. PRA and aldosterone assays were run in duplicate and averaged. Aldosterone was measured using a competition-based radioimmunoassay (ALDOCTK-2; Diasorin, Stillwater, MN). Intra-assay coefficients of variation ranged from 6.30% to 8.87%. Angiotensin I levels directly correlate with PRA. Therefore, PRA was measured using a radioimmunoassay of generated angiotensin I (GammaCoat PRA 125 I Kit; DiaSorin, Stillwater, MN The adjustments for waist circumference were performed because of prior literature demonstrating an association of aldosterone with adiposity, 15 which is independently associated with insulin resistance and diabetes mellitus. 16 ACEinhibitors and ARBs modulate the RAAS system and thus were included in Model 3. Unadjusted type 2 diabetes mellitus incidence rates for log-aldosterone were calculated using person-time analysis assuming a Poisson distribution. Participants were censored at the last attended follow-up exam or development of type 2 diabetes mellitus, whichever came first. Incidence rate ratios were assessed using the MantelCox method. Cox proportional hazards modeling was used to estimate hazard ratios (HR) associated with the aforementioned classifications after confirming no significant violations of the proportional hazards assumption using Schoenfeld residuals. Sequential multivariable adjustment modeling was performed: Model 1 through Model 3 were the same as the cross-sectional adjustments, Model 4: Model 2+log-PRA for log-aldosterone analyses/log-aldosterone for log-PRA analyses. Statistical significance was defined as 2-sided a<0.05.
To assess the role of adipokines and inflammation in the aldosterone/PRA-incident type 2 diabetes mellitus associations, we added to Model 2 and 3 sets of covariates assessing adipokines (leptin and adiponectin) and inflammatory markers (high-sensitivity C-reactive protein (hsCRP), interleukin-6 and tumor necrosis factor alpha (TNF-a) or both. Additionally, we assessed the shape of the association of aldosterone with incident type 2 diabetes mellitus using cubic spline regression with knots at the 25th, 50th, and 75th percentiles of aldosterone to explore potential non-linear relationships.
Analyses were performed using 3 different exposures with incident diabetes mellitus as the outcome, to provide insight into the physiology of aldosterone/renin in the association with incident diabetes mellitus; first, log-aldosterone:PRA ratio was set as an exposure as has been performed to test for primary hyperaldosteronism (a state of autonomous aldosterone production). 17 Second, participants were classified into 3 categories of PRA of ≤0.50, 0.51 to 0.99, and ≥1.0 lg/L per hour, to characterize "suppressed renin phenotype (a state of autonomous aldosterone production)," "indeterminate renin phenotype," and "unsuppressed renin phenotype" (a state of potentially appropriate mineralocorticoid receptor activation in the setting of physiologic renin-dependent secretion of aldosterone). The referent category (≥1.0 lg/L per hour) was compared with the 0.51 to 0.99 and ≤0.50 lg/L per hour categories for the association with incident diabetes mellitus. 9 Third, participants were classified into 3 categories of PRA of ≤0.50, 0.51 to 0.99, and ≥1.0 lg/L per hour and the association of log-aldosterone with incident diabetes mellitus was assessed among participants in the 3 PRA classifications. 9 Given that the association of aldosterone with type 2 diabetes mellitus risk may differ by age, sex, waist circumference, and race/ethnicity, we tested for interaction of these factors with log-aldosterone by inserting an interaction term in the model using unadjusted and Model 1 adjustments. The likelihood ratio test was used to test for significance, defined as P<0.10 for interactions. The interactions for age, sex, and waist circumference were nonsignificant. The interaction of Chinese Americans versus the other racial/ethnic groups was significant in the continuous association of log-aldosterone with incident type 2 diabetes mellitus (P=0.0489 unadjusted and P=0.0885 adjusted) (Table S1 ). Analyses were performed using Stata 13.1 (Statacorp, College Station, TX).
Role of the Funding Source
The funding sources had no role in the collection, analysis, and interpretation of data; writing of the report; or the decision to submit for publication.
Results
The baseline characteristics at visit of aldosterone/renin measurement for the 1570 participants across tertiles of log aldosterone are presented in Table 1 . Compared with those in the lowest tertile, participants in higher tertiles of log aldosterone at baseline had higher diastolic blood pressure, glucose, HOMA2-IR, HOMA2-b, PRA, interleukin-6, TNF-a, alcohol use, and lower estimated glomerular filtration rate, (all comparisons, P<0.05). Baseline characteristics by race/ ethnicity are presented in Table S2 . Blacks had the lowest aldosterone and PRA levels, whereas NHWs had the highest aldosterone and PRA levels (P<0.01).
The cross-sectional associations of aldosterone and PRA with FPG, log HOMA2-IR, and log-HOMA2-b, are summarized in Table 2 . A 100% increase in aldosterone was associated with a 2.58 mg/dL (0.14 mmol/L) higher FPG (95% confidence interval (CI): 1.69, 3.48), 15% higher HOMA2-IR (95% CI: 10%, 19%), and a 4% higher HOMA2-b (95% CI: 1%, 7%) (Model 3). A 100% increase in PRA was associated with a 1.04 mg/dL (0.06 mmol/L) higher FPG (95% CI; 0.61, 1.47), 6% higher HOMA2-IR (95% CI: 4%, 8%) and a 2% higher HOMA2-b (95% CI: 0%, 3%) (Model 3). The association of log aldosterone with FPG varied by race/ethnicity (Table S3) , a 100% increase in aldosterone was associated with a 3.8 mg/ dL (0.21 mmol/L), 3.2 mg/dL (0.18 mmol/L), 2.3 mg/dL (0.13 mmol/L) higher FPG among Chinese Americans, blacks, and NHWs, respectively (all P<0.05) and was non-significant among Hispanic Americans (Model 3). The association of log PRA with FPG was only significant among NHWs (b-coefficient 1.31, P<0.01, Model 3) (Table S3) .
Longitudinal Assessments
During a median follow-up of 10.5 years, 116 participants developed type 2 diabetes mellitus (incidence rate 7.9 per 1000 person-years). Incident rates for log-aldosterone were higher in tertiles 2 and 3 (10.7 and 9.3 per 1000 personyears) compared with tertile 1 (3.6 per 1000 person-years) (P<0.01) in Table 3 . The HRs for the association of logaldosterone and log PRA with incident type 2 diabetes mellitus are presented in Table 3 . After Model 3 adjustment including waist circumference and ACE-I/ARBs, a 1-SD increase in log-aldosterone was associated with a 44% higher risk of incident type 2 diabetes mellitus (HR 1.44, 95% CI: 1.16, 1.78). Similarly, the second and third tertile of log- Table 4) . In regard to log-PRA (Table 3) , after Model 2 adjustments including waist circumference, a 1-SD increase in log-PRA was associated with a 27% higher risk of incident type 2 diabetes mellitus (HR 1.27, 95% CI: 1.04, 1.54). After Model 2 adjustments, participants in tertile 3 versus tertile 1 had a 72% higher risk of incident type 2 diabetes mellitus (HR 1.72, 95% CI: 1.04, 2.84). These findings were attenuated and nonsignificant after adjustment for ACE-I/ARB medications and categorical analyses were non-significant after adjustment for ACE-I/ARB medications (Model 3).
Formal race/ethnicity interaction testing was significant for Chinese Americans versus the other racial/ethnic groups (Table S1 ). Thus, we proceeded with race/ethnicity stratified analyses ( The association of log-aldosterone by renin phenotypes, renin phenotypes alone and log-aldosterone:renin ratio with incident type 2 diabetes mellitus are presented in Table 6 . Participants with PRA ≥1.0 lg/L per hour had a 66% higher risk of incident type 2 diabetes mellitus per 1-SD higher logaldosterone (HR 1.66, 95% CI: 1.08, 2.23) and participants with PRA ≤0.50 lg/L per hour had a 79% higher risk of incident type 2 diabetes mellitus (HR 1.79, 95% CI: 1.21, 2.64) per 1-SD higher log-aldosterone in models adjusted for age, education, sex, study site, race, alcohol, physical activity, estimated glomerular filtration rate, systolic blood pressure, waist circumference, and ACE-I/ARBs. These findings remained significant after exclusion of participants taking ACE-I/ARBs. The association PRA of ≥1.0 lg/L per hour compared with ≤0.51 to 0.99 and 0.50 lg/L per hour with incident type 2 diabetes mellitus was non-significant. Additionally, the association of log-aldosterone/PRA ratio with incident diabetes mellitus was non-significant.
Discussion
In this contemporary, prospective study of multiethnic adults without type 2 diabetes mellitus, higher aldosterone and PRA were associated with higher FPG and insulin resistance at baseline, along with higher risk of incident type 2 diabetes mellitus over 10.5 years. The associations of aldosterone with abnormalities of glucose homeostasis were independent of known type 2 diabetes mellitus risk factors including age, socioeconomic status, race/ethnicity, physical activity, waist circumference, adipokines (leptin and adiponectin) and inflammation (hsCRP, interleukin-6, TNF-a). Additionally, PRA did not modify the association, suggesting that the effects of aldosterone are independent of not only known type 2 diabetes mellitus risk factors but also PRA. On the contrary, the association of PRA with incident type 2 diabetes mellitus was attenuated and became non-significant after adjustment for ACE-I and ARBs or aldosterone. Type 2 diabetes mellitus risk was higher per log-aldosterone SD among participants with both unsuppressed renin phenotype and suppressed renin phenotype indicating that individuals with physiologically and autonomously higher aldosterone are both at higher risk of type 2 diabetes mellitus. There were differences in the magnitude of the associations of aldosterone with type 2 diabetes mellitus across racial/ethnic groups with Chinese Americans having the strongest associations. In the tertile and spline analyses, there were dose-dependent associations of aldosterone with incident type 2 diabetes mellitus in Chinese Americans and blacks but not in Hispanic Americans or NHWs, suggesting potential underlying differences in physiology.
Mechanisms
Preclinical studies suggest that aldosterone induced mineralocorticoid activation increases insulin resistance and impairs insulin secretion. 2 Aldosterone inhibits insulin signaling and insulin-stimulated glucose uptake via glut-4 translocation in adipocytes, skeletal muscle, and vascular smooth muscle cells, as well as a reduction in adiponectin and peroxisome proliferator-activated receptor-gamma. 3, 4 Aldosterone impairs b-cell function and insulin secretion, in 
Model 2 (adipokines) n=1542
Model 1+log-leptin and log-adiponectin 1.38 (1.12, 1.72)
Model 3 (inflammatory markers) n=1493
Model 1+log-hsCRP, log-IL-6, and log-TNF-a 1.38 (1.10, 1.71)
Model 4 (adipokines+inflammatory markers) n=1488
Model 1+log-leptin, log-adiponectin, log-hsCRP, log-IL-6, and log-TNF-a 
Model 3 (inflammatory markers) n=1423
Model 1+log-hsCRP, log-IL-6, and log-TNF-a 1.14 (0.92, 1.41)
Model 4 (adipokines+inflammatory markers) n=1417
Model 1+log-leptin, log-adiponectin, log-hsCRP, log-IL-6, and log-TNF-a 1.12 (0.91, 1.38)
hsCRP indicates high-sensitivity C-reactive protein; IL-6, interleukin 6; TNF-a, tumor necrosis factor-a. *Model 1 adjustments: age, education, sex, study site, race, alcohol, physical activity, estimated glomerular filtration rate, systolic blood pressure, waist circumference (cm), angiotensinconverting enzyme inhibitors, and angiotensin receptor blockers.
preclinical models through blunted glucose-stimulated insulin secretion, moreover, in aldosterone synthase deficient mice glucose-stimulated insulin secretion is markedly increased.
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Consistent with these findings, we found higher insulin resistance and lower compensatory b-cell function with higher levels of aldosterone, suggesting the inability of the b-cell to increase compensatory insulin secretion in the face of higher insulin resistance may be critical in the pathophysiology of type 2 diabetes mellitus. In our study, Chinese Americans and blacks had graded associations of aldosterone with incident type 2 diabetes mellitus and greater magnitude of associations for Chinese Americans. There are many plausible mechanisms including salt-sensitivity, production of aldosterone, receptor binding, and post-receptor signal transduction in response to aldosterone. In the Dahl Salt-Sensitive rat, aldosterone is suppressed acutely in response to salt loads, but aldosterone becomes paradoxically elevated over time. 19 Inappropriate RAAS activation, combined with the maladaptive inability to lower aldosterone levels in response to high salt intake constitute a major issue in all ethnicities, but may be especially relevant in populations with higher levels of saltsensitivity including individuals of Chinese and African ancestry. 20, 21 We have previously shown a dose-response relationship between aldosterone and incident type 2 diabetes mellitus among blacks. 6 In MESA, blacks had the lowest serum aldosterone compared with the other racial/ethnic groups, but importantly, the level may be less critical than the post-receptor signaling cascade evoked by aldosterone. Concordant with this hypothesis, a study of blacks and NHWs found lower aldosterone in blacks during childhood and adulthood, but positive associations of plasma aldosterone with blood pressure only among blacks. 22 Furthermore, administration of 9-a fludrocortisone (synthetic steroid with mineralocorticoid receptor activity) increased blood pressure in blacks but not NHWs. 22 Aldosterone is synthesized by aldosterone synthase (CYP11B2). The most studied polymorphism of CYP11B2 is T- 344C in the promoter region and the polymorphism is associated with higher aldosterone levels. 23, 24 In a large population of individuals of Chinese and Japanese ancestry, CYP11B2 polymorphisms (Arg-173 and T-344C) were associated with higher FPG levels, higher 2-hour post load glucose, impaired fasting glucose and type 2 diabetes mellitus, 25 which is consistent with our findings of a high risk of type 2 diabetes mellitus in Chinese Americans with higher levels of aldosterone. Additionally, a prospective Japanese cohort study with 10 years of follow-up demonstrated that plasma aldosterone levels predict the development of insulin resistance, 26 suggesting our findings might extend to individuals with ancestry from the continent of Asia. Thus, genetic differences in production or response to aldosterone may be responsible for racial/ethnic differences. Our finding that aldosterone's association with glucose metabolism is independent of PRA is consistent with observations made in the pathological state of primary aldosteronism, which is associated with higher levels of insulin resistance. 3 The treatment of primary aldosteronism with adrenalectomy or mineralocorticoid receptor antagonism improves insulin sensitivity and insulin secretion. 27, 28 The largest pharmacologic diabetes mellitus prevention trials examining RAAS antagonism as a primary end point, the DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) study and the NAVIGATOR (Nateglinide and Valsartan in Impaired Glucose Tolerance Outcome Research) study, both showed modest reductions in risk of diabetes mellitus with an ACE-I or ARB, which were significant in NAVIGATOR (14% risk reduction; P<0.0001). 29, 30 These trials were majority NHW and the graded associations of aldosterone with incident diabetes mellitus among blacks and Chinese Americans but not among NHWs, suggests a potential for greater risk reduction with modulation of the RAAS system among blacks and Chinese Americans. Consistent with this hypothesis, incident diabetes mellitus was analyzed as a secondary end point in the AASK trial (African American Study of Kidney Disease and Hypertension Trial) and in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J). 29, 31, 32 Among black participants in AASK ramipril (ACE-I) compared with metoprolol or amlodipine was associated with a 36% reduction (95% CI: 0.45-0.90) in incident diabetes mellitus. 29 Among Japanese participants in CASE-J, candesartan versus placebo was associated with a 36% relative risk reduction (hazard ratio: 0.64; 95% CI: 0.43-0.97; P=0.033) with similar blood pressure reductions in both groups. When considered in comparison to the 9% and 14% diabetes mellitus risk reduction in DREAM and NAVIGATOR, these findings provide additional support for the possibility of racial/ethnic differences in the glycemic response to modulation of the RAAS system. Notably, although these are secondary analyses, the diabetes mellitus risk reduction of 36% in both the AASK and CASE-J trials are greater than the 31% diabetes mellitus risk reduction with metformin in the Diabetes Prevention Program, a medication currently recommended by national guidelines for prevention/delay of type 2 diabetes mellitus.
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Strengths and Limitations Figure. Race/ethnicity-specific associations of aldosterone with incident diabetes mellitus. The cubic spline regressions estimate the hazard ratio of incident diabetes mellitus, according to concentrations of aldosterone (picograms per milliliter, pg/mL) examined as a continuous variable up to the 99th percentile with 3 knots placed at the 25th, 50th, and 75th percentiles. Splines are adjusted for age, sex, study site, education, current alcohol use, physical activity, estimated glomerular filtration rate, systolic blood pressure, and waist circumference. Below each spline is the histogram of the distribution of aldosterone concentration among participants with detectable aldosterone (n=1548). 
Perspectives
In conclusion, our study suggests that higher levels of aldosterone are associated with insulin resistance and incident type 2 diabetes mellitus among multiethnic individuals, suggesting pleiotropic effects of aldosterone may be relevant to the pathogenesis of type 2 diabetes mellitus. The greatest magnitude of association of aldosterone with incident type 2 diabetes mellitus was in Chinese Americans and dose-dependent responses were seen in Chinese Americans and blacks. Further research to elucidate mechanisms for the racial/ethnic differences in the association of aldosterone with incident type 2 diabetes mellitus is of preeminent importance given the potential to lower risk of type 2 diabetes mellitus through targeted modulation of the RAAS system. 
